关于2020年版《中华人民共和国药典》(一部)部分植物药材来源或性状描述的商榷  

The Revision Suggestions on the Description of Macroscopic Characters or Origins of Some Medicinal Plant Materials in 2020 Edition of Chinese Pharmacopoeia(VolumeⅠ)

作　　者：程江雪[1,2] 程虎印 郭东艳[1,2] 史亚军[1,2] CHENG Jiangxue;CHENG Huyin;GUO Dongyan;SHI Yajun(College of Pharmacy,Shaanxi University of Chinese Medicine,Xianyang 712046,China;Shaanxi Province Key Laboratory of Basic and New Herbal Medicament Research,Xianyang 712046,China)

机构地区：[1]陕西中医药大学药学院,陕西咸阳712046 [2]陕西省中药基础与新药研究重点实验室,陕西咸阳712046

出　　处：《中国中医药信息杂志》2021年第7期5-10,共6页Chinese Journal of Information on Traditional Chinese Medicine

基　　金：陕西中医药大学学科创新团队建设项目(2019-YL11)。

摘　　要：本文根据有关学科理论并结合观察实物药材,发现2020年版《中华人民共和国药典》(一部)有47种药材来源或性状描述存在概念或提法错误、表述不够清晰完整或使用非专业术语等问题,为此提出相应修正意见和建议,以更准确反映药材来源和性状特征,为进一步规范药材来源及性状鉴别的科学表述进行有益探索。By comparing the related discipline theory and observing the physical medicinal plant materials,we found that in 2020 edition of Chinese Pharmacopoeia(volumeⅠ),there exist some problems in the description of the macroscopic characters or the origins of 47 medicinal plant materials,including conceptual or formulation mistake,the description is unclear and incompletely,or the non-technical terms were used in the description.And some revision and improvement suggestions have been proposed so as to reflect the macroscopic characters more accurately.It is a useful exploration for further regulate the scientific description of the macroscopic characters of medicinal plant materials.

关 键 词：中华人民共和国药典 法定药用植物 植物药材 药材性状 建议 

分 类 号：R282[医药卫生—中药学]